Agreement further validates Global AI’s ability to scale revenue-critical financial workflows across high-volume industries New York, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Global AI Inc. (OTC: GLAI), a leader in enterprise artificial intelligence (AI), agentic products and solutions, today announced that it has signed a contract with a European commercial airline, transforming revenue mapping from a growth constraint into a scalable driver of financial performance. Under the agreement, Global AI is implementing ...

Prioritizing viewer attention and leveraging advanced analytics, advertisers can effectively drive measurable, meaningful business results through the Nexxen DSP Platforms like Philo and DIRECTV Advertising are enhancing inventory with audience insights and unique formats to meet buyer demand for quality and attention NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Nexxen (NASDAQ: NEXN), a global, flexible advertising platform with deep expertise in data and advanced TV, and H/L, a renowned multiservice and ind ...

HOUSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Glow Holdings, Inc. (OTC: GLOH), doing business as GlohCo, today provided a corporate update following the recent introduction of its GlohCo health intelligence platform and initial engagement across the mental and behavioral health sector. Following its January announcement, management engaged with clinicians, treatment center owners, operators, and business development leaders across mental health, behavioral health, and substance use disorder care, including par ...

Board-certified medical oncologist and hematologist Ravikumar Vasireddy, MD, has cared for patients in the Muskogee community for more than 20 yearsMUSKOGEE, Okla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- RKV Medical Center (RKV), a trusted provider of cancer and blood disorder care in Muskogee and surrounding communities, today announced it has joined American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices, becoming the network’s first partner practice ...

Enterprises seek a holistic strategy to manage all kinds of identities, including humans, machines, and agentsAUSTIN, Texas, Feb. 04, 2026 (GLOBE NEWSWIRE) -- SailPoint, Inc. (Nasdaq: SAIL), a leader in unified identity security for enterprises, is today showcasing how its customers are embracing the new era of adaptive identity security. As businesses increasingly adopt AI and automation, they face a growing challenge: securing an explosion of non-human identities such as machines and AI agents. SailPoint ...

TEL AVIV, Israel, Feb. 04, 2026 (GLOBE NEWSWIRE) -- HUB Cyber Security Ltd. (Nasdaq: HUBC) (“HUB” or the “Company”), a global leader in confidential computing and secured data fabric technologies, today announced an open letter by its CEO, Noah Hershcoviz, to its shareholders. Dear Shareholders, HUB operates in environments where trust failure is not an option. The Company’s foundation is built on military-grade cybersecurity and Secured Data Fabric (“SDF”) infrastructure designed to secure, govern, and ope ...

As a Private Company, Dayforce to Accelerate Growth, Customer Value, and AI Leadership in HCMMINNEAPOLIS and TORONTO and SAN FRANCISCO, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Thoma Bravo, the world’s largest software-focused investment firm, today announced the completion of its acquisition of Dayforce, Inc. (“Dayforce” or the “Company”), a global human capital management (HCM) leader that makes work life better, for approximately US$12.3 billion. The agreement to acquire Dayforce was previously announced on Aug ...

Core Insights - GRI Bio, Inc. reported a cash position of $8.2 million as of December 31, 2025, and raised an additional $6.5 million in January 2026, strengthening its balance sheet to fund operations into Q1 2027 [1][4] - The company announced strong Phase 2a clinical data for GRI-0621 in idiopathic pulmonary fibrosis (IPF), reinforcing its clinical proof-of-concept and therapeutic differentiation [1][8] - GRI-0803, focused on autoimmune indications with high unmet need, is advancing through IND-enabling activities [1][8] Financial Summary - For the year ended December 31, 2025, GRI Bio reported a net loss of $12 million, with research and development expenses increasing to $6.8 million from $3.8 million in 2024, primarily due to the registration development program of GRI-0621 [5] - General and administrative expenses rose to $5.2 million in 2025 from $4.5 million in 2024, mainly due to increased personnel costs [6] Recent Highlights - The company raised approximately $14.5 million in gross proceeds in December 2025 and January 2026, ensuring a strong cash position to fund operations into Q1 2027 [8] - Positive Phase 2a topline data from the completed clinical study of GRI-0621 in IPF was announced, along with additional data demonstrating suppression of pro-fibrotic immune phenotypes [8] - New RNA-sequencing gene expression data was generated, showing a direct impact on the core biology of fibrosis and lung repair [8] - Plans to progress GRI-0803 into IND-enabling studies were advanced, expanding the company's pipeline in autoimmune diseases [8]

Marks Key Milestone in Global AI Data Center Initiative Provides Rapid Entry into Malaysia’s High-Growth AI Data Center Market Miami, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Core AI Holdings, Inc. (Nasdaq: CHAI) (“Core AI” or the “Company”), a global AI-focused technology and investment platform, today announced that it entered into a Memorandum of Understanding (MOU) with CSPM Resources SDN BHD (“CSPM”), one of Malaysia’s most experienced and respected data center developers, to pursue next-generation AI-ready d ...

Landsbankinn will offer ISK denominated additional tier 1 (AT1) securities for sale via auction to be held on Wednesday 11 February 2026. One series of non-indexed AT1 securities (the “Securities”) will be on offer with no fixed maturity date but with a potential call date for the issuer after 5.5 years, subject to the terms and conditions of the Securities, including receipt of prior supervisory permission, as set out in the terms and conditions of the Securities. The Securities will bear a fixed interest ...